DrugPatentWatch Database Preview

Ranbaxy Company Profile

« Back to Dashboard

What is the competitive landscape for RANBAXY, and what generic and branded alternatives to RANBAXY drugs are available?

RANBAXY has forty-four approved drugs.

There are seventeen tentative approvals on RANBAXY drugs.

Summary for Ranbaxy

US Patents:	0
Tradenames:	32
Ingredients:	29
NDAs:	44
Patent Litigation for Ranbaxy:	See patent lawsuits for Ranbaxy
PTAB Cases with Ranbaxy as petitioner:	See PTAB cases with Ranbaxy as petitioner

Drugs and US Patents for Ranbaxy

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ranbaxy	CEFACLOR	cefaclor	FOR SUSPENSION;ORAL	064155-001	Oct 2, 1997		DISCN	No	No
Ranbaxy Labs Ltd	RANICLOR	cefaclor	TABLET, CHEWABLE;ORAL	065092-004	Dec 22, 2003		DISCN	No	No
Ranbaxy Labs Ltd	DISPERMOX	amoxicillin	TABLET, FOR SUSPENSION;ORAL	065080-001	Aug 11, 2003		DISCN	No	No
Ranbaxy Labs Ltd	RANICLOR	cefaclor	TABLET, CHEWABLE;ORAL	065092-002	Dec 22, 2003		DISCN	No	No

Expired US Patents for Ranbaxy

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Ranbaxy	AVENTYL	nortriptyline hydrochloride	SOLUTION;ORAL	014685-001	Approved Prior to Jan 1, 1982	3,922,305

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Ranbaxy
• Ranbaxy Labs Ltd